Speaker: Eric M. Meslin, PhD, FRSC, FCAHS, ICD.D.
The proposed uses of AI in the health sector have elicited reactions from hope to handwringing to hype. In response, governments, NGOs, professional organizations, and the standards community have been busy developing guidelines, frameworks, principles, and other oversight tools with the laudable intention of crafting responsible governance policy for AI in health. Yet with so many players and documents in circulation, it is not surprising that there are gaps, inconsistencies, and contradictions, impeding the very progress such work was meant to enable.
Giving the talk, Dr Eric Meslin examined the roots and causes of these impediments, including those in the bioethics and governance communities themselves, and considered what steps might be taken now to ensure that health care can benefit from AI for the right reasons.
As well as Dr Eric Meslin, we also thank respondents Dr Jeffrey M Skopek and Dr Kristin-Anne Rutter
You can watch video of the WYNG-Hatton lecture here, on the website of the Centre for Medical Ethics and Law, University of Hong Kong.
Following the lecture, on 18 April colleagues from three collaborating centres of excellence in medical law and medical ethics – Hong Kong (CMEL, HKU), Cambridge (LML and PHG Foundation, University of Cambridge), and Montreal (CGP, McGill University) – met to unpick and explore the challenges policy makers face when regulating AI.